KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Other Accumulated Expenses (2016 - 2026)

Medtronic's Other Accumulated Expenses history spans 13 years, with the latest figure at $3.5 billion for Q1 2026.

  • For Q1 2026, Other Accumulated Expenses fell 0.62% year-over-year to $3.5 billion; the TTM value through Jan 2026 reached $3.5 billion, down 0.62%, while the annual FY2025 figure was $3.7 billion, 2.82% up from the prior year.
  • Other Accumulated Expenses for Q1 2026 was $3.5 billion at Medtronic, up from $3.2 billion in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $4.0 billion in Q4 2022 and bottomed at $3.2 billion in Q4 2025.
  • The 5-year median for Other Accumulated Expenses is $3.6 billion (2023), against an average of $3.6 billion.
  • The largest annual shift saw Other Accumulated Expenses rose 16.2% in 2022 before it fell 18.16% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $4.0 billion in 2022, then fell by 18.16% to $3.3 billion in 2023, then dropped by 1.18% to $3.3 billion in 2024, then dropped by 3.28% to $3.2 billion in 2025, then increased by 11.13% to $3.5 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Other Accumulated Expenses are $3.5 billion (Q1 2026), $3.2 billion (Q4 2025), and $3.6 billion (Q3 2025).